Skip to main content
. 2019 Dec 6;12(2):126–133. doi: 10.3892/mco.2019.1961

Figure 2.

Figure 2.

(A) Functional QOL scale for different courses of the 5-days-on/2-days-off regimen of capecitabine for adjuvant chemotherapy for CRC. (B) Symptom QOL scale for different courses of the 5-days-on/2-days-off regimen of capecitabine for CRC adjuvant chemotherapy. There was no significant difference from the score prior to treatment for any of the items. n.s., no significance; QOL, quality of life; CRC, colorectal cancer.